Logo Lucerna-Chem
+41 41 420 9636

Regulatory Status

Article Status


MR837


Catalog Number Pack Size List Price* Promo Price* Quantity
HY-138283-5MG 5 mg 132,00 112,20 Add
HY-138283-10MG 10 mg 216,00 183,60 Add
HY-138283-25MG 25 mg 358,00 304,30 Add
HY-138283-50MG 50 mg 656,00 557,60 Add
HY-138283-100MG 100 mg 935,00 794,80 Add

* CHF, excl. 7.7% VAT and shipping costs


Product Description

MR837 is an inhibitor of NSD2-PWWP1. MR837 can bind with human nuclear receptor binding SET domain protein 2 (PWWP domain).

Category Biochemicals
Supplier MedChem Express
Application Cancer-programmed cell death
Regulatory Status RUO
Format Solubility: Methanol : 125 mg/mL (442.70 mM; Need ultrasonic) ; DMSO : 100 mg/mL (354.16 mM; Need ultrasonic)
Grade Clinical information: No Development Reported
Molecular Formula C16H14N2OS
Molecular Weight 282.36
CAS-Number [1210906-48-1]
Storage Conditions Please store the product under the recommended conditions in the Certificate of Analysis.
Product Line Research
Tech. Data Sheet View datasheet
Link To Supplier http://www.medchemexpress.com
Material Safety Data Sheet Download PDF
Call us

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56
info@lucerna-chem.ch

Business Hours
From Monday through Friday
08:00 – 12:00
13:00 – 17:00

Ask us

Technical Support
tech@lucerna-chem.ch

Business Development
business.dev@lucerna-chem.ch

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern

Newsletter













If you have already subscribed to our newsletter and would like to update your details or cancel it, please click here.


© Copyright 2021 Lucerna-Chem AG, Switzerland